GSK Has Faith In Egypt

BMI View: Egypt's pharmaceutical market has not yet been fundamentally changed by the political upheaval. If anything, 2011 is likely to be a year in which the industry sees very little legislative activity directed towards the regulation of pharmaceuticals. Nevertheless, the industry needs to look to its representatives and lobby groups to identify future allies within the possible electoral candidates to promote their

To read the full article, please choose one of the following options: